Invex Therapeutics Ltd
ASX:IXC
Invex Therapeutics Ltd
ASX:IXC
Price:
0.12
AUD
Market Closed
Market Cap:
AU$9m
Income Statement
Earnings Waterfall
Invex Therapeutics Ltd
Invex Therapeutics Ltd
Income Statement
Invex Therapeutics Ltd
Invex Therapeutics Ltd
Currency: AUD
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue |
0
N/A
|
0
+68%
|
0
-2%
|
1
+218%
|
1
+51%
|
1
-33%
|
2
+103%
|
1
-15%
|
0
-68%
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(2)
|
(3)
|
(4)
|
(7)
|
(9)
|
(7)
|
(3)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Research & Development |
(1)
|
(2)
|
(3)
|
(5)
|
(7)
|
(6)
|
(2)
|
(0)
|
(0)
|
|
| Operating Income |
(2)
N/A
|
(3)
-32%
|
(4)
-31%
|
(6)
-52%
|
(8)
-29%
|
(6)
+22%
|
(2)
+73%
|
0
N/A
|
(0)
N/A
|
|
| Pre-Tax Income | ||||||||||
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(2)
N/A
|
(3)
-32%
|
(4)
-31%
|
(6)
-52%
|
(8)
-29%
|
(6)
+22%
|
(2)
+73%
|
0
N/A
|
(0)
N/A
|
|
| Net Income | ||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(2)
|
(3)
|
(4)
|
(6)
|
(8)
|
(6)
|
(2)
|
0
|
(0)
|
|
| Net Income (Common) |
(2)
N/A
|
(3)
-32%
|
(4)
-31%
|
(6)
-52%
|
(8)
-29%
|
(6)
+22%
|
(2)
+73%
|
0
N/A
|
(0)
N/A
|
|
| EPS (Diluted) |
-0.03
N/A
|
-0.04
-33%
|
-0.05
-25%
|
-0.08
-60%
|
-0.1
-25%
|
-0.08
+20%
|
-0.02
+75%
|
0
N/A
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
